RayPilot

At this year’s ESTRO Congress in Vienna, Austria, Micropos Medical hosted a seminar on augmented stereotactic body radiation therapy (SBRT), a concept encompassing technologies for motion tracking and enhanced methods for accuracy in radiotherapy for prostate cancer, with a focus on treatment outcomes and quality of life. The seminar brought together experts in the field […]

Edinburgh Cancer Centre has recently begun treating prostate cancer patients within the framework of the Precision Study. Patients receive only three radiation doses, with the Raypilot System used as a complement to ensure accurate motion control during treatment, thereby minimising potential side effects. The aim is to demonstrate that three sessions work as well as […]

Men with localised prostate cancer are often faced with the choice of treating the disease with surgery or radiation. Both methods are equally effective in curing the cancer, but the extent of potential side effects varies. A long-term study shows that sexual function deteriorates significantly more, and for more patients, following surgery. Urinary incontinence issues […]

Results have been published from a British long-term follow-up study of 874 prostate cancer patients who received either conventional radiation therapy in 20 or 39 sessions or stereotactic body radiotherapy (SBRT) involving higher radiation doses in five sessions. The results showed that treatment outcomes are equally effective for patients treated five times compared to those […]

Micropos chief executive officer Tomas Gustafsson, sales consultant Irina Sandin, BIR chief executive Jacqueline Fowler and Micropos sales director Kauko Haapasaari. The British Institute of Radiology (BIR) has welcomed Micropos Medical as a corporate member.  Micropos Medical is a Swedish medical technology company that provides the RayPilot system.  This system offers secure real-time target tracking […]